You have 9 free searches left this month | to do more
Showing 1 - 25 of
>10,000 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
K
Recruiting
  • Covid19
  • COVID-19 neutralizing antibody
  • Daegu, Korea, Republic of
    Kyungpook National University Hospital
2021-10-18
Oct 18, 2021
L
Terminated
  • Synovial Sarcoma
  • ipilimumab
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
2021-06-23
Jun 23, 2021
S
Active, not recruiting
  • Pyoderma
  • +3 more
  • Monoclonal antibody (Mab) sB24M
  • Minsk, Belarus
  • +1 more
2021-06-10
Jun 10, 2021
L
Completed
  • Ovarian Cancer
  • 90Y-hu3S193
  • 111In-hu3S193
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
2021-11-23
Nov 23, 2021
S
Not yet recruiting
  • Cholangiocarcinoma, Intrahepatic
  • +2 more
  • PD-L1 antibody combined with CTLA-4 antibody
  • Shanghai, China
    Zhongshan hospital
2020-11-17
Nov 17, 2020
K
Not yet recruiting
  • Healthy
    • (no location specified)
    2021-08-17
    Aug 17, 2021
    B
    Not yet recruiting
    • PD-1 Antibody
    • Mixed Chimerism
    • Toripalimab Injection
    • Beijing, Beijing, China
      Beijing Friendship Hospital, Capital Medical University
    2021-06-27
    Jun 27, 2021
    B
    Recruiting
    • Hemophagocytic Lymphohistiocytosis
    • DEP combine with PD-1 antibody
    • Beijing, China
      Beijing Friendship Hospital, Capital Medical University
    2021-12-08
    Dec 8, 2021
    I
    Completed
    • SARS-CoV-2
    • +2 more
    • Immediate vs. delayed provision of antibody test results
    • Bloomington, Indiana
      Indiana University
    2021-08-23
    Aug 23, 2021
    L
    Terminated
    • Colorectal Cancer
    • monoclonal antibody hu3S193
    • New York, New York
      Memorial Sloan-Kettering Cancer Center
    2021-07-15
    Jul 15, 2021
    F
    Recruiting
    • Thyroid Cancer
    • multiple tyrosine kinase inhibitor(mTKI) Combined with anti-PD-1 antibody
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    2021-05-17
    May 17, 2021
    Y
    Recruiting
    • Neuroblastoma
    • +2 more
    • Humanized 3F8 Bispecific Antibody
    • Blood draw
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    2021-05-24
    May 24, 2021
    I
    Completed
    • SARS-CoV-2
    • SARS-CoV-2 IgG Antibody Testing Kit
    • Indianapolis, Indiana
      Indiana University Health Hospital
    2021-09-10
    Sep 10, 2021
    S
    Recruiting
    • Recurrent Nasopharyngeal Carcinoma
    • PD-1 blocking antibody
    • +2 more
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    2021-11-28
    Nov 28, 2021
    F
    Not yet recruiting
    • Cystic Fibrosis
      • (no location specified)
      2021-12-14
      Dec 14, 2021
      S
      Not yet recruiting
      • Relapsed or Refractory DLBCL
      • Anti-PD-1 Antibody Plus Chidamide and Rituximab
      • (no location specified)
      2021-11-09
      Nov 9, 2021
      G
      Active, not recruiting
      • HER2 Positive Breast Carcinoma
      • +6 more
      • Palo Alto, California
        Stanford University, School of Medicine
      2021-01-21
      Jan 21, 2021
      B
      Not yet recruiting
      • HCC
      • +3 more
      • (no location specified)
      2021-08-28
      Aug 28, 2021
      L
      Recruiting
      • Cervical Cancer
      • ZKAB001 5mg/kg
      • +2 more
      • Beijing, Beijing, China
        Chinese Academy of Medical Sciences and Peking Union Medical Col
      2021-05-10
      May 10, 2021
      Z
      Recruiting
      • Pancreatic Cancer
      • Anti-PD-1 monoclonal antibody
      • Hangzhou, Zhejiang, China
        the First Affiliated Hospital, School of Medicine, Zhejiang Univ
      2021-07-18
      Jul 18, 2021
      A
      Recruiting
      • Solid Tumor
      • Non Hodgkin Lymphoma
      • ADG106 injection
      • PD-1 antibody injection
      • Guangzhou, Guangdong, China
        Sun Yat-Sen University Cancer Center
      2022-01-11
      Jan 11, 2022
      W
      Recruiting
      • Relapsed/Refractory Lymphoma
      • Recombinant humanized anti-CD47/PD-1 bifunctional antibody HX009 injection
      • Beijing, Beijing, China
        Cancer Hospital Chinese Academy of Medical Sciense
      2022-01-10
      Jan 10, 2022
      N
      Not yet recruiting
      • COVID-19
      • Organ Transplant
      • Casirivimab and Imdevimab Antibody Cocktail
      • Manhasset, New York
        Northwell Health Organ Transplant Center
      2021-12-13
      Dec 13, 2021
      B
      Recruiting
      • EBV Infection
      • Beijing, Beijing, China
        Beijing Friendship Hospital, Capital Medical University
      2022-01-04
      Jan 4, 2022
      L
      Recruiting
      • Advanced Urothelial Carcinoma
      • anti-PD-L1 antibody
      • albumin bound paclitaxel
      • Beijing, Beijing, China
        Beijing Tumor Hospital
      2021-05-10
      May 10, 2021